On the stock market since 2019, it operates in the world of real estate. It has 63 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Cost Efficiency: As sales grow, profit fails to keep the same pace.
The stock trades 56% below its peak. The market has trimmed its expectations for the company.
Sales run at $108.9M a year. A small number, but proof the product has real buyers.
The average analyst price target is $6.13 — 27% above today’s price.
It pays out $0.59 per share each year — regular cash for whoever holds the stock.
A loss of $256.4M against $108.9M in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
Over the last 12 months, executives reported 16 sells against just 5 buys. Not an alarm bell by itself, but a number worth watching.
On our five-subject report card, BRMK sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: BRMK is a high-risk stock — not yet profitable, and its future rides on its product catching on.